Literature DB >> 31268184

Meta-analysis of randomized clinical trials of early versus delayed cholecystectomy for mild gallstone pancreatitis.

N Moody1, A Adiamah1, F Yanni1, D Gomez1.   

Abstract

BACKGROUND: Gallstones account for 30-50 per cent of all presentations of acute pancreatitis. While the management of acute pancreatitis is usually supportive, definitive treatment of gallstone pancreatitis is cholecystectomy. Guidelines from the British Society of Gastroenterology suggest definitive treatment on index admission or within 2 weeks of discharge, whereas joint recommendations from the International Association of Pancreatology and the American Pancreatic Association recommend definitive treatment on index admission. Evidence suggests that uptake of these guidelines is low.
METHODS: Embase, MEDLINE and Cochrane databases were searched for RCTs investigating early versus delayed cholecystectomy in patients with a confirmed diagnosis of mild gallstone pancreatitis. The pooled synthesis was undertaken using a random-effects meta-analysis of the primary outcome of recurrent biliary complications causing hospital readmission. Secondary outcomes included intraoperative and postoperative complications, and total length of hospital stay (LOS). All analyses were performed using RevMan5 software.
RESULTS: Five RCTs were identified, which included 629 patients (318 in the early cholecystectomy (EC) group and 311 in the delayed cholecystectomy (DC) group). Recurrent biliary events that required readmission were reduced in patients undergoing EC compared with the number in patients having DC (odds ratio (OR) 0·17, 95 per cent c.i. 0·09 to 0·33). There was no difference in the rate of intraoperative (OR 0·58, 0·17 to 1·92) or postoperative (OR 0·78, 0·38 to 1·62) complications.
CONCLUSION: EC following mild gallstone pancreatitis does not increase the risk of intraoperative or postoperative complications, but reduces the readmission rate for recurrent biliary complications.
© 2019 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Year:  2019        PMID: 31268184     DOI: 10.1002/bjs.11221

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

Review 1.  A narrative review of the mechanism of acute pancreatitis and recent advances in its clinical management.

Authors:  Zhi Zheng; Yi-Xuan Ding; Yuan-Xu Qu; Feng Cao; Fei Li
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis with Mild Pancreatitis.

Authors:  Lu Wang; Hai-Feng Yu; Tong Guo; Peng Xie; Zhi-Wei Zhang; Ya-Hong Yu
Journal:  Curr Med Sci       Date:  2020-10-29

3.  Early vs late cholecystectomy in mild gall stone pancreatitis: An updated meta-analysis and review of literature.

Authors:  Saqib Walayat; Muhammad Baig; Srinivas R Puli
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

Review 4.  A narrative review of acute pancreatitis and its diagnosis, pathogenetic mechanism, and management.

Authors:  Zhi Zheng; Yi-Xuan Ding; Yuan-Xu Qu; Feng Cao; Fei Li
Journal:  Ann Transl Med       Date:  2021-01

5.  Cholecystectomy for people aged 50 years or more with mild gallstone pancreatitis: predictors and outcomes of index and interval procedures.

Authors:  Jian D Blundell; Robert C Gandy; Jacqueline Close; Lara Harvey
Journal:  Med J Aust       Date:  2022-04-22       Impact factor: 12.776

Review 6.  Gallstone pancreatitis: general clinical approach and the role of endoscopic retrograde cholangiopancreatography.

Authors:  Shanker Kundumadam; Evan L Fogel; Mark Andrew Gromski
Journal:  Korean J Intern Med       Date:  2021-01-01       Impact factor: 2.884

7.  Cutting out Cholecystectomy on Index Hospitalization Leads to Increased Readmission Rates, Morbidity, Mortality and Cost.

Authors:  Karthik Gangu; Aniesh Bobba; Harleen Kaur Chela; Omer Basar; Robert W Min; Veysel Tahan; Ebubekir Daglilar
Journal:  Diseases       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.